Bionative AB
Umeå, SE· latest recorded location
Bionative AB is named on 4 US grants and 0 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 4
- Published applications
- 0
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 8 Nov 2005
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 1 | 0 |
By publication year.
Technology areas
Share of 4 documents
Recent patents
- Modification of interferon alpha production8 Nov 2005US 6,962,695 B1
- Process for continuous purification and concentration of leukocytes from blood1 Jun 2004US 6,743,624 B1
- Methionine containing animal cell culture medium and its use30 Oct 2001US 6,309,862 B1
- Interferon purification process21 Feb 1995US 5,391,713 A
No published applications.
Most cited
By later US patents